Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study from the University of Oxford shows that people who hold coronavirus conspiracy beliefs are less likely to comply with social distancing guidelines or take-up future vaccines.

The research, led by clinical psychologists at the University of Oxford and published today in the journal Psychological Medicine, indicates that a disconcertingly high number of adults in England do not agree with the scientific and governmental consensus on the coronavirus pandemic. The findings indicated that: 

  • 60% of adults believe to some extent that the government is misleading the public about the cause of the virus
  • 40% believe to some extent the spread of the virus is a deliberate attempt by powerful people to gain control
  • 20% believe to some extent that the virus is a hoax

From 4 to 11 May 2020, 2,500 adults, representative of the English population for age, gender, region, and income, took part in the Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS). Results indicate that half of the nation is excessively mistrustful and that this reduces the following of government coronavirus guidance.

Daniel Freeman, Professor of Clinical Psychology, University of Oxford, Consultant Clinical Psychologist, Oxford Health NHS Foundation Trust, and study lead, said: 'Our study indicates that coronavirus conspiracy beliefs matter. Those who believe in conspiracy theories are less likely to follow government guidance, for example, staying home, not meeting with people outside their household, or staying 2m apart from other people when outside. Those who believe in conspiracy theories also say that they are less likely to accept a vaccination, take a diagnostic test, or wear a facemask.'

Read more on the University of Oxford website

Similar stories

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.